Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients-Reference-Cited by-同舟云学术

Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients

Published:2013 Issue:1 Volume:36 Page:29-36
ISSN:1421-9735
Container-title:Blood Purification
language:en
Short-container-title:Blood Purif

Author:

Nishio Angie,Chhatkuli Bed P.,Ma Jennie Z.,Kalantari Kambiz

Publisher

S. Karger AG

Subject

Nephrology,Hematology,General Medicine

Reference31 articles.

1. Anemia and Iron Management

2. Effect of Epoetin Alfa Dose Changes on Hemoglobin and Mortality in Hemodialysis Patients with Hemoglobin Levels Persistently below 11 g/dL

3. Association of Mean Weekly Epoetin Alfa Dose with Mortality Risk in a Retrospective Cohort Study of Medicare Hemodialysis Patients

4. Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10‐Year Outcomes of the Q‐Cohort Study;Journal of the American Heart Association;2024-08-06

2. Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis;PLOS ONE;2023-11-09

3. Treatment of Anemia in Kidney Disease: Beyond Erythropoietin;Kidney International Reports;2021-10

4. Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients;Blood Purification;2021-06-25

5. The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis;BMC Nephrology;2021-01-18